173 related articles for article (PubMed ID: 37880286)
1. Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates.
Sahsuvar S; Guner R; Gok O; Can O
Sci Rep; 2023 Oct; 13(1):18225. PubMed ID: 37880286
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
3. Redox-Sensitive and Folate-Receptor-Mediated Targeting of Cervical Cancer Cells for Photodynamic Therapy Using Nanophotosensitizers Composed of Chlorin e6-Conjugated β-Cyclodextrin via Diselenide Linkage.
Kim H; Kim MW; Jeong YI; Yang HS
Cells; 2021 Aug; 10(9):. PubMed ID: 34571839
[TBL] [Abstract][Full Text] [Related]
4. Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin.
Cheng B; Xu P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32927695
[TBL] [Abstract][Full Text] [Related]
5. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
6. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
7. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
8. UM-6 induces autophagy and apoptosis via the Hippo-YAP signaling pathway in cervical cancer.
Wang D; He J; Dong J; Wu S; Liu S; Zhu H; Xu T
Cancer Lett; 2021 Oct; 519():2-19. PubMed ID: 34161791
[TBL] [Abstract][Full Text] [Related]
9. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin.
Do N; Weindl G; Grohmann L; Salwiczek M; Koksch B; Korting HC; Schäfer-Korting M
Exp Dermatol; 2014 May; 23(5):326-31. PubMed ID: 24661024
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
11. Furan-Conjugated Tripeptides as Potent Antitumor Drugs.
Ali H; Jabeen A; Maharjan R; Nadeem-Ul-Haque M; Aamra H; Nazir S; Khan S; Olleik H; Maresca M; Shaheen F
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339257
[TBL] [Abstract][Full Text] [Related]
12. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
Rady I; Siddiqui IA; Rady M; Mukhtar H
Cancer Lett; 2017 Aug; 402():16-31. PubMed ID: 28536009
[TBL] [Abstract][Full Text] [Related]
13. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
[TBL] [Abstract][Full Text] [Related]
16. A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.
Sanches PR; Carneiro BM; Batista MN; Braga AC; Lorenzón EN; Rahal P; Cilli EM
Amino Acids; 2015 Jul; 47(7):1433-43. PubMed ID: 25868656
[TBL] [Abstract][Full Text] [Related]
17. Hollow microspheres based on - Folic acid modified - Hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies.
Metaxa AF; Efthimiadou EK; Boukos N; Fragogeorgi EA; Loudos G; Kordas G
J Colloid Interface Sci; 2014 Dec; 435():171-81. PubMed ID: 25261841
[TBL] [Abstract][Full Text] [Related]
18. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
19. Anticancer activity of drug conjugates in head and neck cancer cells.
Majumdar D; Rahman MA; Chen ZG; Shin DM
Front Biosci (Elite Ed); 2016 Jun; 8(3):358-69. PubMed ID: 27100344
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]